Healthy volunteers help Fine-Tune new drug formulation
NCT ID NCT06670950
First seen Jun 10, 2026 · Last updated Jun 23, 2026 · Updated 1 time
Summary
This early-stage study in 28 healthy adults aims to compare how well a new formulation of the drug SYT-510 is absorbed, and whether food changes its effects. Part 1 looks at single doses under different conditions, while Part 2 tests multiple doses to check safety and how the drug moves through the body. The results will guide future dosing decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Richmond Pharmacology Ltd
London, United Kingdom
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SYT-510
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.